What Is Sipagladenant?
Sipagladenant is a small-molecule adenosine A2A receptor antagonist and inverse agonist. Its developmental code in the peer-reviewed literature is KW-6356 (CAS 858979-50-7, C20H19N3O4S, 397.4 g/mol, PubChem CID 23144148). It is not a xanthine. The misspelling “sipaglandenant” and the catalog code KW-6353 both show up in search logs; identity checks should land on CAS 858979-50-7 and CID 23144148.
Chemical Identity of Sipagladenant
Sipagladenant is N-[4-(furan-2-yl)-5-(oxane-4-carbonyl)-1,3-thiazol-2-yl]-6-methylpyridine-3-carboxamide. The thiazole core, furan, and tetrahydropyran ketone make a compact non-xanthine ligand that docks into A2A in published crystal structures.


Molecular Data
| Property | Value |
|---|---|
| CAS# | 858979-50-7 |
| PubChem ID | CID 23144148 |
| Molecular Formula | C20H19N3O4S |
| Molecular Weight | 397.40 g/mol |
| Exact Mass | 397.1096 Da |
| IUPAC Name | N-[4-(furan-2-yl)-5-(oxane-4-carbonyl)-1,3-thiazol-2-yl]-6-methylpyridine-3-carboxamide |
| InChIKey | KMFLQPJJHQNKKF-UHFFFAOYSA-N |
| SMILES | CC1=NC=C(C=C1)C(=O)NC2=NC(=C(S2)C(=O)C3CCOCC3)C4=CC=CO4 |
| Molecular Class | Small molecule (non-peptide); adenosine A2A receptor antagonist |
| Stereocenters | 0 defined, 0 undefined |
| Hydrogen bond donors / acceptors | 1 / 7 |
| XLogP3 (computed) | 2.5 |
Values from PubChem CID 23144148 (computed by PubChem).
Key Chemical Identifiers
| Item | Detail | Source |
|---|---|---|
| INN | sipagladenant | WHO / FDA UNII |
| Literature code | KW-6356 | PMID 36894319 |
| Catalog alias | KW-6353 (verify CAS) | Supplier listings |
| Misspelling | sipaglandenant | Search logs |
| CAS / CID | 858979-50-7 / 23144148 | PubChem |
| Formula / MW | C20H19N3O4S / 397.4 | PubChem |
| InChIKey | KMFLQPJJHQNKKF-UHFFFAOYSA-N | PubChem |
| UNII | FF2012ZV92 | FDA SRS |
When KW-6353 and KW-6356 disagree on a packing slip, the CAS and InChIKey settle the argument.
How Does Sipagladenant Work?
It binds the adenosine A2A receptor as a selective antagonist and inverse agonist. Ohno and colleagues compared KW-6356 with istradefylline in functional assays and solved cocrystal structures that explain why the non-xanthine ligand behaves differently at the same receptor (Mol Pharmacol 2023, PMID 36894319). Population pharmacokinetic modeling further characterizes KW-6356 and an active metabolite in published clinical pharmacology studies (PMID 38178727).
Sipagladenant vs. Istradefylline
Both target A2A, but istradefylline is a xanthine while sipagladenant is not. Structural and functional papers treat that scaffold difference as the reason inverse-agonist behavior and binding poses diverge. Choose the tool that matches the assay’s chemical and pharmacological controls, not only the receptor name on the tube.
Naming Traps: KW-6356, KW-6353, and Sipaglandenant
The peer-reviewed record and PubChem title the molecule sipagladenant / KW-6356. Commercial pages sometimes print KW-6353 next to the same INN, and search boxes often receive the misspelling sipaglandenant. None of those strings invent a second substance by themselves, but they do invent a second freezer label if nobody checks CAS 858979-50-7.
A calm lab rule is enough: accept the bottle only when the certificate’s CAS and InChIKey match CID 23144148. Keep KW-6356 in the citation field and KW-6353 in an “also labeled as” note if the carton needs it. That small habit prevents months of confused reorder emails.
Formats and Testing for Research
Research suppliers list sipagladenant / KW-6356 as a small-molecule solid with third-party identity testing. Match CAS 858979-50-7 on the certificate even if the bottle also prints KW-6353. See HPLC testing for analytical habits.
Related Research Tools
References
- Ohno Y, et al. In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2A Receptor Antagonist/Inverse Agonist. Mol Pharmacol. 2023;103(6):311-324. PMID 36894319
- Tayama T, et al. Population Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356… Clin Pharmacol Drug Dev. 2024. PMID 38178727
- PubChem CID 23144148: Sipagladenant. PubChem
Frequently Asked Questions
What Is Sipagladenant?
Sipagladenant is the INN for a non-xanthine selective adenosine A2A receptor antagonist and inverse agonist developed as KW-6356 (CAS 858979-50-7, formula C20H19N3O4S, 397.4 g/mol, PubChem CID 23144148). Some supplier catalogs list it as KW-6353; PubChem and the FDA UNII map the INN to KW-6356.
Is Sipaglandenant the Same Compound?
Sipaglandenant is a common misspelling of sipagladenant. Searches with the extra n still refer to the A2A ligand at CID 23144148 when the CAS or KW code matches.
Is Sipagladenant a Xanthine Like Caffeine?
No. Sipagladenant is a non-xanthine 2-aminothiazole carrying furan and tetrahydropyran-4-carbonyl groups. That scaffold separates it chemically from caffeine and from the xanthine A2A antagonist istradefylline.
How Does Sipagladenant Work?
In vitro pharmacology shows KW-6356 acts as a selective A2A antagonist and inverse agonist, with cocrystal structures versus istradefylline clarifying the binding differences (Ohno et al., 2023, PMID 36894319).
What Is the Difference Between KW-6356 and KW-6353?
Primary papers and PubChem use KW-6356 for sipagladenant. KW-6353 appears on some commercial listings for the same INN; treat KW-6356 as the literature code and confirm CAS 858979-50-7 on the certificate.
What Identifiers Should Be Recorded?
INN sipagladenant; codes KW-6356 / KW6356; CAS 858979-50-7; CID 23144148; UNII FF2012ZV92; InChIKey KMFLQPJJHQNKKF-UHFFFAOYSA-N.